The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview

Abstract Introduction Cardiac arrhythmias, including ventricular tachycardia (VT), stand as a significant threat to health, often leading to mortality and sudden cardiac death. While conventional treatments for VT exhibit efficacy, cases of refractory VT pose challenges. Stereotactic Arrhythmia Radi...

Full description

Bibliographic Details
Main Authors: Farzad MasoudKabir, Reyhaneh Bayani, Nima Mousavi Darzikolaee, Alireza Abdshah, Mahsa Moshtaghian, Farshid Farhan, Mahdi Aghili, Ali Kazemian, Luca Nicosia, Francesco Cuccia, Ana Vitoria Rocha, Fatemeh Jafari, Filippo Alongi
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Health Science Reports
Subjects:
Online Access:https://doi.org/10.1002/hsr2.1741
_version_ 1797375200722944000
author Farzad MasoudKabir
Reyhaneh Bayani
Nima Mousavi Darzikolaee
Alireza Abdshah
Mahsa Moshtaghian
Farshid Farhan
Mahdi Aghili
Ali Kazemian
Luca Nicosia
Francesco Cuccia
Ana Vitoria Rocha
Fatemeh Jafari
Filippo Alongi
author_facet Farzad MasoudKabir
Reyhaneh Bayani
Nima Mousavi Darzikolaee
Alireza Abdshah
Mahsa Moshtaghian
Farshid Farhan
Mahdi Aghili
Ali Kazemian
Luca Nicosia
Francesco Cuccia
Ana Vitoria Rocha
Fatemeh Jafari
Filippo Alongi
author_sort Farzad MasoudKabir
collection DOAJ
description Abstract Introduction Cardiac arrhythmias, including ventricular tachycardia (VT), stand as a significant threat to health, often leading to mortality and sudden cardiac death. While conventional treatments for VT exhibit efficacy, cases of refractory VT pose challenges. Stereotactic Arrhythmia Radioablation (STAR) offers a novel approach, delivering precise high‐dose radiation to well‐defined targets with minimal collateral damage. This study explores the potential of STAR as an alternative therapy, especially for high‐risk patients or those with refractory VT. Methods This research reviews ongoing studies and preliminary investigations into the evaluation of the efficacy and safety of STAR. The method involves targeted radiation delivery, assessing reductions in VT recurrence and the early safety profile in refractory VT patients. However, given STAR's early stage and limited clinical evidence, cautious interpretation is advised. Results Preliminary findings indicate a reduction in VT recurrence with STAR, suggesting promise as a therapeutic option. Early safety profiles are encouraging, but definitive statements on efficacy and safety require further investigation. Positive initial outcomes underscore the need for additional data and long‐term studies. Conclusion Stereotactic Arrhythmia Radioablation is recently emerging as a promising treatment for refractory VT. While early results are encouraging, careful interpretation is needed, due to STAR's early stages. Ongoing investigations are critical for a comprehensive understanding of its long‐term efficacy and tolerability. This review provides fundamental insights into STAR's background, principles, pre‐treatment procedures, clinical implications, and toxicity, setting the stage for future research in this evolving therapeutic field.
first_indexed 2024-03-08T19:18:50Z
format Article
id doaj.art-b50c334542fb413697f3fe1cf5029a89
institution Directory Open Access Journal
issn 2398-8835
language English
last_indexed 2024-03-08T19:18:50Z
publishDate 2023-12-01
publisher Wiley
record_format Article
series Health Science Reports
spelling doaj.art-b50c334542fb413697f3fe1cf5029a892023-12-27T00:48:32ZengWileyHealth Science Reports2398-88352023-12-01612n/an/a10.1002/hsr2.1741The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overviewFarzad MasoudKabir0Reyhaneh Bayani1Nima Mousavi Darzikolaee2Alireza Abdshah3Mahsa Moshtaghian4Farshid Farhan5Mahdi Aghili6Ali Kazemian7Luca Nicosia8Francesco Cuccia9Ana Vitoria Rocha10Fatemeh Jafari11Filippo Alongi12Cardiac Primary Prevention Research Center Tehran University of Medical Sciences Tehran IranDepartment of Radiation Oncology Hamadan University of Medical Sciences Hamadan IranRadiation Oncology Research Center (RORC) Tehran University of Medical Sciences Tehran IranSchool of Medicine Tehran University of Medical Sciences Tehran IranCancer Research Center, Cancer institute of Iran, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran IranCancer Research Center, Cancer institute of Iran, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran IranCancer Research Center, Cancer institute of Iran, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran IranDepartment of Radiation Oncology, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran IranAdvanced Radiation Oncology Department IRCCS Ospedale Sacro Cuore Don Calabria Negrar‐Verona ItalyAdvanced Radiation Oncology Department IRCCS Ospedale Sacro Cuore Don Calabria Negrar‐Verona ItalyDivision of Medicine Federal University of Goias Goiânia BrazilCancer Research Center, Cancer institute of Iran, Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran IranAdvanced Radiation Oncology Department IRCCS Ospedale Sacro Cuore Don Calabria Negrar‐Verona ItalyAbstract Introduction Cardiac arrhythmias, including ventricular tachycardia (VT), stand as a significant threat to health, often leading to mortality and sudden cardiac death. While conventional treatments for VT exhibit efficacy, cases of refractory VT pose challenges. Stereotactic Arrhythmia Radioablation (STAR) offers a novel approach, delivering precise high‐dose radiation to well‐defined targets with minimal collateral damage. This study explores the potential of STAR as an alternative therapy, especially for high‐risk patients or those with refractory VT. Methods This research reviews ongoing studies and preliminary investigations into the evaluation of the efficacy and safety of STAR. The method involves targeted radiation delivery, assessing reductions in VT recurrence and the early safety profile in refractory VT patients. However, given STAR's early stage and limited clinical evidence, cautious interpretation is advised. Results Preliminary findings indicate a reduction in VT recurrence with STAR, suggesting promise as a therapeutic option. Early safety profiles are encouraging, but definitive statements on efficacy and safety require further investigation. Positive initial outcomes underscore the need for additional data and long‐term studies. Conclusion Stereotactic Arrhythmia Radioablation is recently emerging as a promising treatment for refractory VT. While early results are encouraging, careful interpretation is needed, due to STAR's early stages. Ongoing investigations are critical for a comprehensive understanding of its long‐term efficacy and tolerability. This review provides fundamental insights into STAR's background, principles, pre‐treatment procedures, clinical implications, and toxicity, setting the stage for future research in this evolving therapeutic field.https://doi.org/10.1002/hsr2.1741arrhythmiaatrial fibrillationradiation therapyradioablationventricular tachycardia
spellingShingle Farzad MasoudKabir
Reyhaneh Bayani
Nima Mousavi Darzikolaee
Alireza Abdshah
Mahsa Moshtaghian
Farshid Farhan
Mahdi Aghili
Ali Kazemian
Luca Nicosia
Francesco Cuccia
Ana Vitoria Rocha
Fatemeh Jafari
Filippo Alongi
The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview
Health Science Reports
arrhythmia
atrial fibrillation
radiation therapy
radioablation
ventricular tachycardia
title The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview
title_full The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview
title_fullStr The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview
title_full_unstemmed The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview
title_short The state‐of‐the‐art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview
title_sort state of the art technic of stereotactic radioablation for the treatment of cardiac arrhythmias an overview
topic arrhythmia
atrial fibrillation
radiation therapy
radioablation
ventricular tachycardia
url https://doi.org/10.1002/hsr2.1741
work_keys_str_mv AT farzadmasoudkabir thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT reyhanehbayani thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT nimamousavidarzikolaee thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT alirezaabdshah thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT mahsamoshtaghian thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT farshidfarhan thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT mahdiaghili thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT alikazemian thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT lucanicosia thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT francescocuccia thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT anavitoriarocha thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT fatemehjafari thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT filippoalongi thestateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT farzadmasoudkabir stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT reyhanehbayani stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT nimamousavidarzikolaee stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT alirezaabdshah stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT mahsamoshtaghian stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT farshidfarhan stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT mahdiaghili stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT alikazemian stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT lucanicosia stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT francescocuccia stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT anavitoriarocha stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT fatemehjafari stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview
AT filippoalongi stateofthearttechnicofstereotacticradioablationforthetreatmentofcardiacarrhythmiasanoverview